The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive ...
Cigna Healthcare's divestiture of low-margin Medicare businesses will allow focus on employer-sponsored plans. Learn more on ...
The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's ...
Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...
U.S. equities were higher around midday as August retail sales were higher than anticipated and the Fed began its two-day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback